阿尔茨海默病神经病理标志物的研究进展

被引：4

作者：

王海红

肖世富

机构：

[1] 上海交通大学医学院附属精神卫生中心

来源：

上海精神医学 | 2009年 / 21卷 / 01期

关键词：

阿尔茨海默病; ApoE; 等位基因; 磷酸化; 标志物; 老年斑; AD; 特异位点; CJD; CSF; 淀粉样; 血浆; β斑; 肌萎缩侧索硬化;

D O I：

暂无

中图分类号：

R749.1 [脑器质性精神障碍];

学科分类号：

100205 ;

摘要：

引用

页码：55 / 57

页数：3

共 12 条

[1] 脑脊液生物学标志物诊断阿尔茨海默病与血管性痴呆 [J].

薛海波 ;

肖世富 ;

孙云 ;

张明园 .

中国现代神经疾病杂志, 2007, (03) :223-227

[2] 老年性痴呆血浆中Aβ1-42、Aβ1-40及p-tau(181P)蛋白的临床诊断意义 [J].

彭丹涛 ;

许贤豪 ;

孟晓梅 ;

刘江红 ;

谢琰臣 ;

冯凯 .

中国神经免疫学和神经病学杂志, 2005, (04) :208-211

[3] The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease [J].

Giedraitis, Vilmantas ;

Sundelof, Johan ;

Irizarry, Michael C. ;

Garevik, Nina ;

Hyman, Bradley T. ;

Wahlund, Lars-Olof ;

Ingelsson, Martin ;

Lannfelt, Lars .

NEUROSCIENCE LETTERS, 2007, 427 (03) :127-131

[4]

CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment[J] . Alessandro Stefani,Alessandro Martorana,Sergio Bernardini,Marta Panella,Flavio Mercati,Antonio Orlacchio,Mariangela Pierantozzi. Journal of the Neurological Sciences . 2006 (1)

[5]

Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk[J] . R. Mayeux,L. S. Honig,M.-X. Tang,J. Manly,Y. Stern,N. Schupf,P. D. Mehta. Neurology . 2003 (9)

[6] CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study [J].

Strozyk, D ;

Blennow, K ;

White, LR ;

Launer, LJ .

NEUROLOGY, 2003, 60 (04) :652-656

[7] Amyloid beta 1-42, and tau in cerebrospinal fluid after severe traumatic brain injury [J].

Franz, G ;

Beer, R ;

Kampfl, A ;

Engelhardt, K ;

Schmutzhard, M ;

Ulmer, H ;

Deisenhammer, F .

NEUROLOGY, 2003, 60 (09) :1457-1461

[8]

Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome[J] . Nicole Schupf,Bindu Patel,Wayne Silverman,Warren B. Zigman,Nan Zhong,Benjamin Tycko,Pankaj D. Mehta,Richard Mayeux. Neuroscience Letters . 2001 (3)

[9]

CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease[J] . Kaj Blennow,Eugeen Vanmechelen,Harald Hampel. Molecular Neurobiology . 2001 (1)

[10]

Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke[J] . Camilla Hesse,Lars Rosengren,Eugeen Vanmechelen,Hugo Vanderstichele,Christer Jensen,Pia Davidsson,Kaj Blennow. Journal of Alzheimer’s Disease . 2000 (3,4)

← 1 2 →